News > Indiscriminate use of remdesivir, tocilizumab can cause more harm than good

Indiscriminate use of remdesivir, tocilizumab can cause more harm than good

ICMR and AIIMS have asked states to use drugs like Remdesivir and Tocilizumab, mentioned as investigational therapies, on COVID-19 patients strictly as per the laid down protocol as their "indiscriminate use may cause more harm than good".

The two bodies stressed that the treatment approach for COVID-19 is largely based on supportive care since there is no cure as yet. The drugs should be used with caution due to their potential for serious adverse effects including liver and kidney injury.